Back
Redhill Biopharma 10K Form
Sell
15
RDHL
Redhill Biopharma
Last Price:
0.43
Seasonality Move:
-2.12%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RDHL News And Ratings
See the #1 stock for the next 7 days that we like better than RDHL
RDHL Financial Statistics
Sales & Book Value
| Annual Sales: | $6.53M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.88 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -3.80690 |
|---|---|
| Net Income (TTM): | $11.57M |
| Gross Margin: | $3.07M |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Redhill Biopharma Earnings Forecast
Key Redhill Biopharma Financial Ratios
- The Gross Profit Margin over the past 12 years for RDHL is 47.03%.
- The Selling, General & Administrative Expenses for RDHL have been equal to 474.35% of Gross Profit Margin.
- The Research & Development expenses have been 54.03% of Revenue.
- The Interest Expense is 1.53% of Operating Income.
- The Net Earning history of RDHL is 366.25% of Total Revenues.
- Per Share Earnings over the last 14 years have been positive in 7 years.
Redhill Biopharma Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | RDHL |
| CUSIP: | 757468 |
| Website: | redhillbio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
RDHL Technical Analysis vs Fundamental Analysis
Sell
15
Redhill Biopharma (RDHL)
is a Sell
Is Redhill Biopharma a Buy or a Sell?
-
Redhill Biopharma stock is rated a Sell
The current Redhill Biopharma [RDHL] share price is $0.43. The Score for RDHL is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.